Seres Therapeutics, Inc. Other Non-Current Assets
Seres Therapeutics, Inc. (MCRB) had Other Non-Current Assets of $31.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-05
- 2026-06-30: Other Assets, Noncurrent $31.00K.
- 2026-03-31: Other Assets, Noncurrent $31.00K.
- 2025-12-31: Other Assets, Noncurrent $31.00K.
- 2025-09-30: Other Assets, Noncurrent $31.00K.
| Period end | Other Assets, Noncurrent | Other Assets, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $31.00K 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $31.00K 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $31.00K 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $31.00K 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $31.00K 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $31.00K 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $31.00K 10-K · filed 2026-03-12 | |
| 2024-09-30 | $465.00K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $41.52M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $41.47M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $2.19M 10-K · filed 2025-03-13 | $41.35M 10-K · filed 2024-03-05 |
| 2023-09-30 | $12.05M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $11.25M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $11.31M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $10.46M 8-K · filed 2024-08-15 | |
| 2022-09-30 | $11.54M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $9.51M 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $1.74M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $5.19M 10-K · filed 2023-03-07 | |
| 2021-09-30 | $601.00K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $602.00K 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $602.00K 10-Q · filed 2021-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |